Total Payments
$1,665
2024 Payments
$705.40
Companies
21
Transactions
106
Medicare Patients
16,333
Medicare Billing
$772,694
Payment Breakdown by Category
Food & Beverage$1,655 (99.4%)
Education$9.24 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,655 | 103 | 99.4% |
| Education | $9.24 | 3 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| OPKO Pharmaceuticals, LLC | $247.07 | 25 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $238.63 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $198.29 | 12 | $0 (2024) |
| Amgen Inc. | $167.94 | 10 | $0 (2024) |
| GlaxoSmithKline, LLC. | $126.84 | 3 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $112.65 | 6 | $0 (2024) |
| Travere Therapeutics, Inc. | $93.04 | 8 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $79.95 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $72.69 | 3 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $62.66 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $705.40 | 53 | OPKO Pharmaceuticals, LLC ($171.65) |
| 2023 | $472.03 | 25 | GlaxoSmithKline, LLC. ($108.78) |
| 2022 | $487.13 | 28 | Amgen Inc. ($101.90) |
All Payment Transactions
106 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $15.22 | General |
| 11/25/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: NEPHROLOGY | ||||||
| 11/19/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: NEPHROLOGY | ||||||
| 11/19/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $2.03 | General |
| Category: NEPHROLOGY | ||||||
| 11/19/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $1.43 | General |
| Category: NEPHROLOGY | ||||||
| 11/18/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Cardio-renal | ||||||
| 10/24/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: NEPHROLOGY | ||||||
| 10/24/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $1.46 | General |
| Category: NEPHROLOGY | ||||||
| 10/23/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: NEPHROLOGY | ||||||
| 10/10/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Nephrology | ||||||
| 10/09/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: NEPHROLOGY | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Immunology | ||||||
| 09/18/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $15.22 | General |
| 09/18/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 09/03/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: NEPHROLOGY | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/27/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: NEPHROLOGY | ||||||
| 08/27/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $0.93 | General |
| Category: NEPHROLOGY | ||||||
| 08/26/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: NEPHROLOGY | ||||||
| 08/26/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $1.58 | General |
| Category: NEPHROLOGY | ||||||
| 08/19/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 42 | 7,619 | 14,326 | $2.8M | $382,454 |
| 2022 | 44 | 7,002 | 11,413 | $1.2M | $323,325 |
| 2021 | 26 | 1,712 | 2,493 | $252,243 | $66,916 |
Total Patients
16,333
Total Services
28,232
Medicare Billing
$772,694
Procedure Codes
112
All Medicare Procedures & Services
112 procedure records from CMS Medicare Utilization — Page 2 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 36 | 106 | $8,198 | $1,116 | 13.6% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 18 | 21 | $8,355 | $981.54 | 11.7% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 64 | 71 | $7,072 | $969.15 | 13.7% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 64 | 71 | $5,806 | $948.56 | 16.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 19 | 25 | $6,500 | $891.00 | 13.7% |
| 84100 | Phosphate level | Office | 2023 | 166 | 168 | $4,778 | $773.10 | 16.2% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 194 | 249 | $4,736 | $772.18 | 16.3% |
| 83550 | Iron binding capacity | Office | 2023 | 63 | 70 | $3,671 | $599.90 | 16.3% |
| 86160 | Measurement of complement (immune system proteins), antigen, | Office | 2023 | 22 | 42 | $3,024 | $493.92 | 16.3% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 30 | 33 | $2,986 | $487.74 | 16.3% |
| 83540 | Iron level | Office | 2023 | 63 | 70 | $2,717 | $443.80 | 16.3% |
| 82746 | Folic acid level, serum | Office | 2023 | 27 | 29 | $2,558 | $417.89 | 16.3% |
| 84156 | Total protein level, urine | Office | 2023 | 64 | 79 | $1,740 | $284.40 | 16.3% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 32 | 62 | $881.64 | $143.84 | 16.3% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 14 | 14 | $710.64 | $107.77 | 15.2% |
| 85046 | Red blood count automated, with additional calculations | Office | 2023 | 18 | 19 | $634.98 | $103.74 | 16.3% |
| 84300 | Urine sodium level | Office | 2023 | 11 | 17 | $516.12 | $84.32 | 16.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 40 | 333 | $271,708 | $87,496 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 546 | 672 | $204,241 | $59,371 | 29.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 216 | 453 | $135,492 | $34,608 | 25.5% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2022 | 380 | 436 | $73,549 | $17,595 | 23.9% |
| 82306 | Vitamin d-3 level | Office | 2022 | 391 | 486 | $58,801 | $14,048 | 23.9% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2022 | 39 | 2,160 | $79,898 | $13,364 | 16.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 128 | 190 | $39,438 | $9,963 | 25.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 81 | 159 | $33,376 | $8,558 | 25.6% |
About Dr. Cameron Golightly, DO
Dr. Cameron Golightly, DO is a Nephrology healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2016. The National Provider Identifier (NPI) number assigned to this provider is 1821442682.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cameron Golightly, DO has received a total of $1,665 in payments from pharmaceutical and medical device companies, with $705.40 received in 2024. These payments were reported across 106 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,655).
As a Medicare-enrolled provider, Golightly has provided services to 16,333 Medicare beneficiaries, totaling 28,232 services with total Medicare billing of $772,694. Data is available for 3 years (2021–2023), covering 112 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Student in an Organized Health Care Education/Training Program, Nephrology
- Location Chattanooga, TN
- Active Since 04/19/2016
- Last Updated 08/11/2021
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1821442682
Products in Payments
- RAYALDEE (Drug) $247.07
- JYNARQUE (Drug) $238.63
- FARXIGA (Drug) $183.95
- Kerendia (Drug) $112.65
- JESDUVROQ (Drug) $95.86
- Parsabiv (Drug) $89.55
- ACTHAR (Biological) $79.95
- TAVNEOS (Drug) $66.04
- TARPEYO (Drug) $62.66
- LUPKYNIS (Drug) $47.55
- KRYSTEXXA (Biological) $42.48
- Fabhalta (Drug) $41.06
- BENLYSTA (Biological) $30.98
- Veltassa (Drug) $23.52
- Auryxia (Drug) $21.73
- FABRAZYME (Biological) $20.95
- ONPATTRO (Drug) $19.01
- KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) $18.40
- JARDIANCE (Drug) $15.02
- LOKELMA (Drug) $14.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Chattanooga
Rohit Gupta, M.d, M.D
Nephrology — Payments: $10,529
Nephrology $10,529
Hans Yehnert, Md, MD
Nephrology — Payments: $5,326
Nephrology $5,326
Nilesh Patel, M.d, M.D
Nephrology — Payments: $3,184
Nephrology $3,184
John Mccarley, M.d, M.D
Nephrology — Payments: $2,939
Nephrology $2,939
Brant Holt, Md, MD
Nephrology — Payments: $2,929
Nephrology $2,929
Mandeep Grewal, Md, MD
Nephrology — Payments: $2,449
Nephrology $2,449